The U.S. Food and Drug Administration today approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.
Procesadora de Productos Marinos Delifish S.A. Recalls Product Because Of Possible Listeria Monocytogenes Risk
Potential Listeria-positive products have been identified and we can confirm that Delifish S.A.
has issued a voluntary recall of cold smoked salmon products potentially containing Listeria
monocytogenes placed on the market in the USA produced from lots 249 through 291,
manufactured between September 5 2012 and October 17, 2012.
FDA approves first drug to treat multi-drug resistant tuberculosis
On Dec. 28, the U.S. Food and Drug Administration approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available.
FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation
The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
Urgent: ADM Alliance Nutrition Recalling MoorMan’s® ShowTec® 18 Elite Lamb Feed
ADM Alliance Nutrition, Inc. (“Alliance Nutrition”) is recalling 50-pound bags of MoorMan’s® ShowTec® 18 Elite Lamb DC, product number 80939MPS, because the product has high levels of copper. There are three lot numbers involved in this recall: BF23512, BF27812, and BF29312.
Voluntary Worldwide Field Corrective Action Issued for the T-piece Circuit used on GE Healthcare’s Giraffe and Panda
GE Healthcare initiated a voluntary worldwide field correction of the T-piece circuit used with GE Healthcare’s Giraffe and Panda resuscitation units. The T-piece circuits affected by this recall are sold under the following part numbers and contain a red inspection stamp (those containing a blue inspections stamp are NOT affected by this recall)
FDA approves new orphan drug for rare cholesterol disorder
On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.
Haig’s Delicacies Announces Voluntary Recall of Tzatziki, Falafel, Spanakopita and
Haig’s Delicacies of Hayward, CA is recalling all Tzatziki, Falafel, Spanakopita and Tyropita because the product labels do not include Allergy Statements reflecting the use of the following food allergens:
Federal judge enters order imposing restrictions on Sunland Inc.
U.S. District Judge William P. Johnson of the District of New Mexico has signed a consent decree imposing requirements on Sunland Inc., a manufacturer and distributor of peanut products linked to an outbreak of Salmonella Bredeney, to keep potentially harmful products from entering the marketplace, the U.S. Food and Drug Administration said today.
S&M INTERNATIONAL INC. Recalls Yang Sheng Cooked Salted Duck Eggs Because of Possible Health Risk
S&M International Inc, Bayonne, NJ is recalling Yang Sheng cooked salted duck eggs, because it has the potential to be contaminated with Clostridium botulinum, a bacterium which can cause serious life-threating illness or death. Consumers are warned not to use the product even if it does not look smelled or spoiled.